Aetna, Inc.
15
0
0
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.7%
1 terminated/withdrawn out of 15 trials
92.9%
+6.4% vs industry average
13%
2 trials in Phase 3/4
15%
2 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Robot-Mediated Intervention for Children With Autism Spectrum Disorders
Role: collaborator
IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation
Role: collaborator
The Effect of a Therapy Dog Activity on Employees' Stress, Mood, and Job Satisfaction and Commitment
Role: collaborator
Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis
Role: collaborator
Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated
Role: collaborator
mHealth Screening to Prevent Strokes
Role: collaborator
Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics
Role: collaborator
Postpartum Weight Retention
Role: collaborator
Our Whole Lives: Online Chronic Pain Management
Role: collaborator
Safety Study of GBS Following Menactra Meningococcal Vaccination
Role: collaborator
A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
Role: collaborator
Aetna_Intel Medicare Home Biomonitoring Study
Role: lead
Testing Strategies to Improving Warfarin Adherence
Role: collaborator
CHOICE: Communicating Health Options Through Information and Cancer Education
Role: collaborator
Patient-Centered Depression Care for African Americans
Role: collaborator
All 15 trials loaded